drugset / Trial / NCT04868045

Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer

NCT04868045

Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to find out whether people who have had thyroid cancer develop resistance to treatment with thyroid hormones after having received high doses of thyroid drugs for many years.

Timeline

Start
2021-04-27
Primary completion
2023-02-15
Completion
2023-02-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Thyrotropin Releasing Hormone (TRH) Unknown 200 ug Intravenous
Background Levothyroxine Other / unclassified

Indications